Erythromycin, 9-oxime(CAS: 13127-18-9)

Erythromycin, 9-oxime (CAS: 13127-18-9) is subject to various regulatory guidelines including the GHS classification for hazardous chemicals, REACH regulations for European Union member states, and FDA/EPA requirements for use in pharmaceuticals and agricultural applications. Compliance with local and international safety standards is essential to ensure product safety and environmental protection.

In synthesis, alternative reagents such as 9-oxoerythromycin A and other macrolides can be considered as alternatives to Erythromycin, 9-oxime. These compounds offer similar antimicrobial properties but may have different advantages in terms of reaction conditions and product yields.

The market for Erythromycin, 9-oxime (CAS: 13127-18-9) reflects a growing interest in advanced antimicrobial agents. Research trends include the development of more potent derivatives and the exploration of its application in novel therapeutic areas such as infectious diseases and inflammatory conditions. Market trends suggest increasing demand driven by rising healthcare costs and the need for effective antibiotics.

Waste containing Erythromycin, 9-oxime (CAS: 13127-18-9) should be collected and handled according to local regulations, typically involving the use of a professional waste disposal service. Incineration is a common method for disposing of hazardous waste, and environmental protection measures should be taken to prevent contamination of soil and water. Proper storage and transportation of waste are also crucial to maintain safety and prevent accidental spills or releases.